AlphaStocks
2.8
Avoid

NEOGENOMICS INC (NEO)

Health Care / Health Care Services

S&P SmallCap 600

$7.76

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

#1032out of 1127 in Health Care

Is NEOGENOMICS INC a Good Investment in 2026?

NEOGENOMICS INC (NEO) scores 2.8 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates NEOGENOMICS INC as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 96%). NEOGENOMICS INC ranks #1032 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-8.5Market Cap994.1M

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 96%)

Frequently Asked Questions

Is NEOGENOMICS INC (NEO) a good investment?
Based on AlphaStocks' composite analysis, NEOGENOMICS INC (NEO) scores 2.8 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Currently unprofitable — fair value estimate not available.
What is NEOGENOMICS INC's Piotroski F-Score?
NEOGENOMICS INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is NEO overvalued or undervalued?
A precise fair value estimate is not available for NEO. Currently unprofitable — fair value estimate not available.
How does NEO compare to other Health Care stocks?
NEOGENOMICS INC ranks #1032 out of 1127 stocks in the Health Care sector, placing it in the top 92% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about NEO?
AlphaStocks evaluates NEO using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 2.8/10.

Similar Stocks

PARRFTIAZN

Compare NEO with

NEO vs PARRNEO vs FTINEO vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer